The role of the D3 dopamine receptor and its partial agonist cariprazine in patients with schizophrenia and substance use disorder
出版年份 2023 全文链接
标题
The role of the D3 dopamine receptor and its partial agonist cariprazine in patients with schizophrenia and substance use disorder
作者
关键词
-
出版物
EXPERT OPINION ON PHARMACOTHERAPY
Volume -, Issue -, Pages 1-8
出版商
Informa UK Limited
发表日期
2023-10-11
DOI
10.1080/14656566.2023.2266359
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Terminal type-specific cannabinoid CB1 receptor alterations in patients with schizophrenia: A pilot study
- (2023) Shinnyi Chou et al. NEUROBIOLOGY OF DISEASE
- Mini Review on Cariprazine: A Promising Antipsychotic Agent
- (2022) Ashish Patel et al. CNS & Neurological Disorders-Drug Targets
- The Potential of N-Acetyl-L-Cysteine (NAC) in the Treatment of Psychiatric Disorders
- (2022) Richard C. J. Bradlow et al. CNS DRUGS
- Atypical Antipsychotic Drugs in Dual Disorders: Current Evidence for Clinical Practice
- (2022) Giovanni Martinotti et al. CURRENT PHARMACEUTICAL DESIGN
- Effects of clozapine treatment on the improvement of substance use disorders other than nicotine in individuals with schizophrenia spectrum disorders: A systematic review and meta-analysis
- (2022) Reza Rafizadeh et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Cariprazine, A Broad-Spectrum Antipsychotic for the Treatment of Schizophrenia: Pharmacology, Efficacy, and Safety
- (2021) István Laszlovszky et al. ADVANCES IN THERAPY
- Case Report: Cariprazine in a Patient With Schizophrenia, Substance Abuse, and Cognitive Dysfunction
- (2021) Jose Rodriguez Cruz et al. Frontiers in Psychiatry
- Reducing Addiction in Bipolar Disorder via Hacking the Dopaminergic System
- (2021) Heinz Grunze et al. Frontiers in Psychiatry
- Case Series: Cariprazine for treatment of methamphetamine use disorder
- (2021) Thanh Thuy Truong et al. AMERICAN JOURNAL ON ADDICTIONS
- Dopamine D3 partial agonists in the treatment of psychosis and substance use disorder comorbidity: a pharmacological alternative to consider?
- (2020) Daniel Hernández-Huerta et al. CNS SPECTRUMS
- The efficacy of cariprazine in negative symptoms of schizophrenia: Post hoc analyses of PANSS individual items and PANSS-derived factors
- (2019) Wolfgang Fleischhacker et al. EUROPEAN PSYCHIATRY
- Trait impulsiveness is related to smaller post-commissural putamen volumes in males but not females
- (2017) Fernando Caravaggio et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- Late Reduction of Cocaine Cravings in a Randomized, Double-Blind Trial of Aripiprazole vs Perphenazine in Schizophrenia and Comorbid Cocaine Dependence
- (2017) Thomas Beresford et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Cariprazine versus risperidone monotherapy for treatment of predominant negative symptoms in patients with schizophrenia: a randomised, double-blind, controlled trial
- (2017) György Németh et al. LANCET
- Pharmacokinetics and Pharmacodynamics of Lurasidone Hydrochloride, a Second-Generation Antipsychotic: A Systematic Review of the Published Literature
- (2016) William M. Greenberg et al. CLINICAL PHARMACOKINETICS
- Mechanism of action of cariprazine
- (2016) Stephen M. Stahl CNS SPECTRUMS
- The dopamine D3 receptor, a quarter century later
- (2016) Pierre Sokoloff et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- Current drug treatments targeting dopamine D3 receptor
- (2016) Gian Marco Leggio et al. PHARMACOLOGY & THERAPEUTICS
- Imaging the D3 dopamine receptor across behavioral and drug addictions: Positron emission tomography studies with [11C]-(+)-PHNO
- (2015) Isabelle Boileau et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Pharmacological treatment of schizophrenia with comorbid substance use disorder
- (2015) Jean-Michel Azorin et al. EXPERT OPINION ON PHARMACOTHERAPY
- The ABC's of dopamine receptor partial agonists - aripiprazole, brexpiprazole and cariprazine: the 15-min challenge to sort these agents out
- (2015) L. Citrome INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- NOW vs LATER brain circuits: implications for obesity and addiction
- (2015) Nora D. Volkow et al. TRENDS IN NEUROSCIENCES
- A Review of the Pharmacology, Efficacy and Tolerability of Recently Approved and Upcoming Oral Antipsychotics: An Evidence-Based Medicine Approach
- (2013) Leslie Citrome CNS DRUGS
- The potential role of dopamine D3 receptor neurotransmission in cognition
- (2013) Shinichiro Nakajima et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Varenicline Treatment of Concurrent Alcohol and Nicotine Dependence in Schizophrenia
- (2013) Zsuzsa Szombathyne Meszaros et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Heightened D3 Dopamine Receptor Levels in Cocaine Dependence and Contributions to the Addiction Behavioral Phenotype: A Positron Emission Tomography Study with [11C]-(+)-PHNO
- (2013) Doris E Payer et al. NEUROPSYCHOPHARMACOLOGY
- Profile of blonanserin for the treatment of schizophrenia
- (2013) Tomomi Tenjin et al. Neuropsychiatric Disease and Treatment
- Co-Occurring Psychotic and Addictive Disorders
- (2012) Stephen Ross et al. CLINICAL NEUROPHARMACOLOGY
- Higher Binding of the Dopamine D3 Receptor-Preferring Ligand [11C]-(+)-Propyl-Hexahydro-Naphtho-Oxazin in Methamphetamine Polydrug Users: A Positron Emission Tomography Study
- (2012) I. Boileau et al. JOURNAL OF NEUROSCIENCE
- Cariprazine (RGH-188), a D3-preferring dopamine D3/D2 receptor partial agonist antipsychotic candidate demonstrates anti-abuse potential in rats
- (2012) V. Román et al. PSYCHOPHARMACOLOGY
- Brain uptake and distribution of the dopamine D3/D2receptor partial agonist [11C]cariprazine: An in vivo positron emission tomography study in nonhuman primates
- (2012) Miklós Tóth et al. SYNAPSE
- Inverted-U–Shaped Dopamine Actions on Human Working Memory and Cognitive Control
- (2011) Roshan Cools et al. BIOLOGICAL PSYCHIATRY
- Pharmacokinetics and metabolism update for some recent antipsychotics
- (2011) Silvio Caccia Expert Opinion on Drug Metabolism & Toxicology
- Decreased dopamine activity predicts relapse in methamphetamine abusers
- (2011) G J Wang et al. MOLECULAR PSYCHIATRY
- Effect of Modafinil on Learning and Task-Related Brain Activity in Methamphetamine-Dependent and Healthy Individuals
- (2011) Dara G Ghahremani et al. NEUROPSYCHOPHARMACOLOGY
- Cariprazine (RGH-188), a Dopamine D3 Receptor-Preferring, D3/D2 Dopamine Receptor Antagonist-Partial Agonist Antipsychotic Candidate: In Vitro and Neurochemical Profile
- (2010) B. Kiss et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Insights into the Substrate Specificity, Inhibitors, Regulation, and Polymorphisms and the Clinical Impact of Human Cytochrome P450 1A2
- (2009) Shu-Feng Zhou et al. AAPS Journal
- Substance Use Disorders in Schizophrenia--Clinical Implications of Comorbidity
- (2009) N. D. Volkow SCHIZOPHRENIA BULLETIN
- Cognitive and antismoking effects of varenicline in patients with schizophrenia or schizoaffective disorder
- (2009) Robert C. Smith et al. SCHIZOPHRENIA RESEARCH
- Aripiprazole in the treatment of patients with alcohol dependence: a double-blind, comparison trial vs. Naltrexone
- (2008) G Martinotti et al. JOURNAL OF PSYCHOPHARMACOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started